Old Web
English
Sign In
Acemap
>
authorDetail
>
Chris Assaid
Chris Assaid
Merck & Co.
Medicine
Sample size determination
Levodopa
Antagonist
Anesthesia
3
Papers
51
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Methodological Extensions of Phase 2 Trial Designs Based on Program-Level Considerations: Further Development of a Case Study in Neuropathic Pain
2017
Therapeutic Innovation & Regulatory Science
James Bolognese
Jaydeep Bhattacharyya
Chris Assaid
Nitin R. Patel
Show All
Source
Cite
Save
Citations (1)
A Two-Stage Adaptive Design in Phase 2 Clinical Trials for Acute Treatment of Migraine
2011
Drug Information Journal
Xiaoyin Frank Fan
Chris Assaid
Yang Joy Ge
Tony W. Ho
Show All
Source
Cite
Save
Citations (0)
Single-Dose Administration of MK-0657, an NR2B-Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease
2009
The Journal of Clinical Pharmacology
Carol Addy
Chris Assaid
David Hreniuk
Mark Stroh
Yang Xu
W. Joseph Herring
Aaron Ellenbogen
H. A. Jinnah
Louis Kirby
Mark Leibowitz
R. Malcolm Stewart
Daniel Tarsy
James Tetrud
S. Aubrey Stoch
Keith M. Gottesdiener
John A. Wagner
Show All
Source
Cite
Save
Citations (50)
1